Pasar al contenido principal

NUEVO BIOMATERIAL BIO-ACTIVO PARA LA REGENERACION DE LESIONES MEDULARES

RTI2018-095872-B-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Regenerative and resorbable PLA/HA hybrid construct for tendon/ligament tissue engineering

  • Araque-Monrós, M. C.
  • García-Cruz, D. M.
  • Escobar-Ivirico, J. L.
  • Gil-Santos, L.
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • Más Estellés, Jorge|||0000-0001-8446-6737
[EN] Tendon and ligament shows extremely limited endogenous regenerative capacity. Current treatments are based on the replacement and or augmentation of the injured tissue but the repaired tissue rarely achieve functionality equal to that of the preinjured tissue. To address this challenge, tissue engineering has emerged as a promising strategy. This study develops a regenerative and resorbable hybrid construct for tendon and ligament engineering. The construct is made up by a hollow poly-lactic acid braid with embedded microspheres carrying cells and an anti-adherent coating, with all the parts being made of biodegradable materials. This assembly intends to regenerate the tissue starting from the interior of the construct towards outside while it degrades. Fibroblasts cultured on poly lactic acid and hyaluronic acid microspheres for 6 h were injected into the hollow braid and the construct was cultured for 14 days. The cells thus transported into the lumen of the construct were able to migrate and adhere to the braid fibers naturally, leading to a homogeneous proliferation inside the braid. Moreover, no cells were found on the outer surface of the coating. Altogether, this study demonstrated that PLA/HA hybrid construct could be a promising material for tendon and ligament repair., This work was supported by AITEX (Textil Research Institute, Alcoi, Alicante, Spain) through the researching contract "Development of braided biomaterials for biomedical applications'' and also funded by AEI "RTI2018-095872-B-C21 and C22/ERDF''.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Nebot, V. J.
  • Dordevic, S.
  • Requejo-Aguilar, R.
  • Alastrue-Agudo, A.
  • Zagorodko, O.
  • Armiñán, A.
  • Martinez-Rojas, B.
  • Vicent, M.J.
  • Moreno Manzano, V.
[EN] Rho/ROCK signaling induced after spinal cord injury (SCI) contributes to secondary damage by promoting apoptosis, inflammation, and axon growth inhibition. The specific Rho-kinase inhibitor fasudil can contribute to functional regeneration after SCI, although inherent low stability has hampered its use. To improve the therapeutic potential of fasudil, we now describe a family of rationally-designed bioresponsive polymer-fasudil conjugates based on an understanding of the conditions after SCI, such as low pH, enhanced expression of specific proteases, and a reductive environment. Fasudil conjugated to poly-l-glutamate via a self-immolative redox-sensitive linker (PGA-SS-F) displays optimal release kinetics and, consequently, treatment with PGA-SS-F significantly induces neurite elongation and axon growth in dorsal root ganglia explants, spinal cord organotypic cultures, and neural precursor cells (NPCs). The intrathecal administration of PGA-SS-F after SCI in a rat model prevents early apoptosis and induces the expression of axonal growth- and neuroplasticity-associated markers to a higher extent than the free form of fasudil. Moreover, a combination treatment comprising the acute transplantation of NPCs pre-treated with PGA-SS-F leads to enhanced cell engraftment and reduced cyst formation after SCI. In chronic SCI, combinatory treatment increases the preservation of neuronal fibers. Overall, this synergistic combinatorial strategy may represent a potentially efficient clinical approach to SCI treatment., This research was funded by FEDER/Ministerio de Ciencia e Innovacion -Agencia Estatal de Investigacion [RTI2018-095872-B-C21/ERDF], Ministerio de Ciencia e Innovacion [SAF2016-80427-R, PID2019-108806RB-I00], Fundacio Marato TV3 [20172230, 20172231 and 20172110] Fundacion Step by Step, Agencia Valenciana de Innovacion (AVI) [INNVAL10/19/047] and MINECO/FEDER, UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Hyaluronic Acid Demilune Scaffold and Polypyrrole-Coated Fibers Carrying Embedded Human Neural Precursor Cells and Curcumin for Surface Capping of Spinal Cord Injuries

  • Elkhenany, Hoda
  • Bonilla, Pablo
  • Alastrue Agudo, Ana
  • Edel, Michael J.
  • Vicent, María Jesus
  • Rodriguez Doblado, Laura
  • Moreno Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Gisbert-Roca, Fernando|||0000-0003-3937-5822
  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
[EN] Tissue engineering, including cell transplantation and the application of biomaterials and bioactive molecules, represents a promising approach for regeneration following spinal cord injury (SCI). We designed a combinatorial tissue-engineered approach for the minimally invasive treatment of SCI¿a hyaluronic acid (HA)-based scaffold containing polypyrrole-coated fibers (PPY) combined with the RAD16-I self-assembling peptide hydrogel (Corning® PuraMatrix¿peptide hydrogel (PM)), human induced neural progenitor cells (iNPCs), and a nanoconjugated form of curcumin (CURC). In vitro cultures demonstrated that PM preserves iNPC viability and the addition of CURC reduces apoptosis and enhances the outgrowth of Nestin-positive neurites from iNPCs, compared to nonembedded iNPCs. The treatment of spinal cord organotypic cultures also demonstrated that CURC enhances cell migration and prompts a neuron-like morphology of embedded iNPCs implanted over the tissue slices. Following sub-acute SCI by traumatic contusion in rats, the implantation of PMembedded iNPCs and CURC with PPY fibers supported a significant increase in neuro-preservation (as measured by greater III-tubulin staining of neuronal fibers) and decrease in the injured area (as measured by the lack of GFAP staining). This combination therapy also restricted platelet-derived growth factor expression, indicating a reduction in fibrotic pericyte invasion. Overall, these findings support PM-embedded iNPCs with CURC placed within an HA demilune scaffold containing PPY fibers as a minimally invasive combination-based alternative to cell transplantation alone., This research was funded by the Science by Women program, Women for Africa Foundation to H.E. and the grants FEDER/Ministerio de Ciencia e Innovacion-Agencia Estatal de Investigacion [RTI2018-095872-B-C21 and -C22/ERDF]; Part of the equipment employed in this work was funded by Generalitat Valenciana and cofinanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). RISEUP project FetOpen in H2020 Program: H2020-FETOPEN-2018-2019-2020-01.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

NPC transplantation rescues sci-driven cAMP/EPAC2 alterations, leading to neuroprotection and microglial modulation

  • Martinez-Rojas, Beatriz
  • Grillo-Risco, Rubén
  • Hidalgo, Marta R.
  • López-Mocholi, Eric
  • Alastrue-Agudo, Ana
  • Garcia-Garcia, Francisco
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
[EN] Neural progenitor cell (NPC) transplantation represents a promising treatment strategy for spinal cord injury (SCI); however, the underlying therapeutic mechanisms remain incompletely understood. We demonstrate that severe spinal contusion in adult rats causes transcriptional dysregulation, which persists from early subacute to chronic stages of SCI and afects nearly 20,000 genes in total tissue extracts. Functional analysis of this dysregulated transcriptome reveals the signifcant downregulation of cAMP signalling components immediately after SCI, involving genes such as EPAC2 (exchange protein directly activated by cAMP), PKA, BDNF, and CAMKK2. The ectopic transplantation of spinal cord-derived NPCs at acute or subacute stages of SCI induces a signifcant transcriptional impact in spinal tissue, as evidenced by the normalized expression of a large proportion of SCI-afected genes. The transcriptional modulation pattern driven by NPC transplantation includes the rescued expression of cAMP signalling genes, including EPAC2. We also explore how the sustained in vivo inhibition of EPAC2 downstream signalling via the intrathecal administration of ESI-05 for 1 week impacts therapeutic mechanisms involved in the NPC-mediated treatment of SCI. NPC transplantation in SCI rats in the presence and absence of ESI-05 administration prompts increased rostral cAMP levels; however, NPC and ESI-05 treated animals exhibit a signifcant reduction in EPAC2 mRNA levels compared to animals receiving only NPCs treatment. Compared with transplanted animals, NPCs+ESI-05 treatment increases the scar area (as shown by GFAP staining), polarizes microglia into an infammatory phenotype, and increases the magnitude of the gap between NeuN+cells across the lesion. Overall, our results indicate that the NPC-associated therapeutic mechanisms in the context of SCI involve the cAMP pathway, which reduces infammation and provides a more neuropermissive environment through an EPAC2-dependent mechanism., This research was funded by FEDER/Ministerio de Ciencia e Innovacion - Agencia Estatal de Investigacion [RTI2018-095872-B-C21/ERDF] and RISEUP EU grant (Ref. 964562) from FetOpen H2020 program. Part of the equipment employed in this work was funded by Generalitat Valenciana and cofinanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. B. Martinez-Rojas was supported by a grant from the Conselleria de Educacion, Investigacion, Cultura y Deporte de la Generalitat Valenciana and the European Social Fundation ACIF/2019/120.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Strategy for Magnetic and Electric Stimulation to Enhance Proliferation and Differentiation of NPCs Seeded over PLA Electrospun Membranes

  • Cuenca-Ortolá, Irene
  • Martinez-Rojas, Beatriz
  • Moreno Manzano, Victoria
  • García Castelló, Marcos
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Más Estellés, Jorge|||0000-0001-8446-6737
[EN] Neural progenitor cells (NPCs) have been shown to serve as an efficient therapeutic strategy in different cell therapy approaches, including spinal cord injury treatment. Despite the reported beneficial effects of NPC transplantation, the low survival and differentiation rates constrain important limitations. Herein, a new methodology has been developed to overcome both limitations by applying a combination of wireless electrical and magnetic stimulation to NPCs seeded on aligned poly(lactic acid) nanofibrous scaffolds for in vitro cell conditioning prior transplantation. Two stimulation patterns were tested and compared, continuous (long stimulus applied once a day) and intermittent (short stimulus applied three times a day). The results show that applied continuous stimulation promotes NPC proliferation and preferential differentiation into oligodendrocytic and neuronal lineages. A neural-like phenotypic induction was observed when compared to unstimulated NPCs. In contrast, intermittent stimulation patterns did not affect NPC proliferation and differentiation to oligodendrocytes or astrocytes morphology with a detrimental effect on neuronal differentiation. This study provides a new approach of using a combination of electric and magnetic stimulation to induce proliferation and further neuronal differentiation, which would improve therapy outcomes in disorders such as spinal cord injury., Grants RTI2018-095872-B-C21/ERDF and RTI2018-095872-B-C22/ERDF funded by MCIN/AEI//10.13039/501100011033 and by ERDF A way of making Europe. This project was also funded by Project 964562 H2020 FetOpen program. Irene Cuenca Ortola acknowledges the grant PRE2019-090716 funded by MCIN/AEI/10.13039/501100011033 and by ESF Investing in your future. B. Martinez Rojas was supported by a grant from the Conselleria de Educacion, Investigacion, Cultura y Deporte de la Generalitat Valenciana and the European Social Fundation ACIF/2019/120.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Transplantation of Human Fetal Spinal cord-derived NPCs Primed with a Polyglutamate-conjugated Rho/Rock Inhibitor as a Therapy for Acute Spinal Cord Injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Bonilla, Pablo
  • Mellado, Mara
  • García-Manau, Pablo
  • Rodó, Carlota
  • Alastrue, Ana
  • López, Eric
  • Carreras Moratonas, Elena
  • Pellisé, Ferran
  • Dordevic, Snezana
  • Vicent, María J.
  • Moreno Manzano, Victoria
[EN] Neural precursor cell (NPC) transplantation represents a promising therapy for treating spinal cord injuries (SCIs); however, despite successful results obtained in preclinical models, the clinical translation of this approach remains challenging due, in part, to the lack of consensus on an optimal cell source for human neuronal cells. Depending on the cell source, additional limitations to NPC-based therapies include high tumorigenic potential, alongside poor graft survival and engraftment into host spinal tissue. We previously demonstrated that NPCs derived from rat fetal spinal cords primed with a polyglutamate (PGA)-conjugated form of the Rho/Rock inhibitor fasudil (PGA-SS-FAS) displayed enhanced neuronal differentiation and graft survival when compared to non-primed NPCs. We now conducted a similar study of human-fetal-spinal-cord-derived NPCs (hfNPCs) from legal gestational interruptions at the late gestational stage, at 19-21.6 weeks. In vitro, expanded hfNPCs retained neural features, multipotency, and self-renewal, which supported the development of a cell banking strategy. Before transplantation, we established a simple procedure to prime hfNPCs by overnight incubation with PGA-SS-FAS (at 50 ¿M FAS equiv.), which improved neuronal differentiation and overcame neurite-like retraction after lysophosphatidic-acid-induced Rho/Rock activation. The transplantation of primed hfNPCs into immune-deficient mice (NU(NCr)-Foxn1nu) immediately after the eighth thoracic segment compression prompted enhanced migration of grafted cells from the dorsal to the ventral spinal cord, increased preservation of GABAergic inhibitory Lbx1-expressing and glutamatergic excitatory Tlx3-expressing somatosensory interneurons, and elevated the numbers of preserved, c-Fos-expressing, activated neurons surrounding the injury epicenter, all in a low percentage. Overall, the priming procedure using PGA-SS-FAS could represent an alternative methodology to improve the capabilities of the hfNPC lines for a translational approach for acute SCI treatment., This research was funded by Fundacio Marato TV3 2017/refs.20172230, 20172231, Agencia Valenciana de Innovacion (AVI) (INNVAL10/19/047 and Grants RTI2018-095872-B-C21 and PDI20211243590B-I00/ERDF funded by MCIN/AEI//10.13039/501100011033 and by ERDF A way of making Europe). This project was also funded by Project 964562 (RISEUP), H2020 FetOpen program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment

  • Bonilla, Pablo
  • Hernandez, Joaquim
  • González-Pérez, Miguel A.
  • Alastrue-Agudo, Ana
  • Elkhenany, Hoda
  • Vicent, María J.
  • Edel, Michael
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Navarro i García, Xavier
[EN] We currently lack effective treatments for the devastating loss of neural function associated with spinal cord injury (SCI). In this study, we evaluated a combination therapy comprising human neural stem cells derived from induced pluripotent stem cells (iPSC-NSC), human mesenchymal stem cells (MSC), and a pH-responsive polyacetal-curcumin nanoconjugate (PA-C) that allows the sustained release of curcumin. In vitro analysis demonstrated that PA-C treatment protected iPSC-NSC from oxidative damage in vitro, while MSC co-culture prevented lipopolysaccharide-induced activation of nuclear factor-kappa B (NF-kappa B) in iPSC-NSC. Then, we evaluated the combination of PA-C delivery into the intrathecal space in a rat model of contusive SCI with stem cell transplantation. While we failed to observe significant improvements in locomotor function (BBB scale) in treated animals, histological analysis revealed that PA-C-treated or PA-C and iPSC-NSC + MSC-treated animals displayed significantly smaller scars, while PA-C and iPSC-NSC + MSC treatment induced the preservation of beta-III Tubulin-positive axons. iPSC-NSC + MSC transplantation fostered the preservation of motoneurons and myelinated tracts, while PA-C treatment polarized microglia into an anti-inflammatory phenotype. Overall, the combination of stem cell transplantation and PA-C treatment confers higher neuroprotective effects compared to individual treatments., This research was funded by Fundacio Marato TV3 2017/refs.20172230, 20172231 and 20172110; FEDER/Ministerio de Ciencia e Innovacion-Agencia Estatal de Investigacion "RTI2018095872-B-C21/ERDF", Agencia Valenciana de Innovacion (AVI) INNVAL10/19/047 and TERCEL (RD12/0019/0011) funds from the Instituto de Salud Carlos III of Spain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Transcriptional Insights for Spinal Cord Injury and Neural Precursor Cell Therapy: Toward a Novel Optogenetics-Based Treatment for cAMP Neuronal Induction

  • Martínez Rojas, Beatriz
[ES] La lesión medular traumática (LM) se refiere a una condición neurológica en la que un insulto mecánico interrumpe la adecuada comunicación de impulsos nerviosos a través del sistema nervioso central (SNC), resultando en la pérdida de función locomotora por debajo del área lesionada. Lamentablemente, en la actualidad aún no existe cura efectiva para restaurar la funcionalidad después de una LM. La búsqueda de un tratamiento eficiente sigue siendo un gran desafío debido a nuestra aún incompleta comprensión de la multitud de procesos biológicos desencadenados por la lesión. La terapia celular destaca como la aproximación más recurrente para el tratamiento de la LM. En las últimas décadas, se han explorado varias estrategias celulares, siendo una de las más prometedoras el trasplante de células progenitoras neurales (CPN). Muchos estudios preclínicos demostrado el potencial del trasplante de CPN para proporcionar una recuperación motora en modelos animales, sin embargo, las mejoras funcionales en ensayos clinicos humanos son limitadas. Por lo tanto, aún se deben realizar esfuerzos para descubrir la cascada precisa de procesos moleculares a lo largo de la fisiopatología de LM, así como el mecanismo subyacente de los CPN. En ese contexto, el Capítulo 1 del presente trabajo tuvo como objetivo proporcionar una caracterización de los cambios en el perfil transcripcional medular a lo largo de las diferentes etapas temporales de una lesión severa contusiva. Además, hemos descrito el impacto transcripcional del trasplante de CPN en ratas lesionadas. Hemos demostrado que mientras la LM conllevó una fuerte desregulación de varios componentes de señalización de AMPc (entre ellos EPAC2), el trasplante de CPN pudo restaurar estas alteraciones transcripcionales. Para explorar el papel de EPAC2 en el mecanismo terapéutico mediado por CPN, realizamos un experimento de inhibición sostenida de EPAC2 mediante la administración de ESI-05. En comparación con los animales solo trasplantados, los animales CPN +ESI-05 mostraron un aumento en el área de cicatriz, una exacerbación de la polarización de la microglía hacia un perfil inflamatorio y una ampliación de la brecha de neuronas preservadas a lo largo de la lesión, sugiriendo que el trnasplante de CPN en el contexto de LM implican un mecanismo dependiente de EPAC2, reduciendo la neuroinflamación y proporcionando un entorno neuro-permisivo. El Capítulo 2 explora el potencial del AMPc para la regeneración de la LM. Hemos diseñado una estrategia innovadora para inducir AMPc en las neuronas corticoespinales a través de la activación optogenética de un adenilato ciclasa foto-inducible (bPAC). La estimulación optogenética en ratas con una hemisección dorsal torácica promovió una recuperación locomotora en comparación con el grupo control. Además, la estimulación de bPAC aumentó el número de neuronas marcadas retrógradamente desde el segmento lumbar tanto en la corteza motora como en la formación rafe-reticular, pero no en el núcleo rojo.La inmunotinción del tracto rafespinal mostró que la estimulación de bPAC aumenta el ratio de axones serotonérgicos caudales a la lesión correlacionando con una mejora funcional. Por último, la depleción del sistema serotoninérgico mediante la administración de 5,7-Dihydroxytryptamina suprimió la abolió la mejora mediada por bPAC, confirmando la implicación de la vía serotoninérgica en la recuperación de los animales estimulados. En resumen, se han proporcionado nuevos conocimientos sobre los cambios transcripcionales que ocurren a lo largo de la progresión de la LM y tras el trasplante de CPN, con énfasis en la señalización de AMPc. La manipulación optogenética de AMPc en las neuronas corticoespinales después de la LM ha demostrado ser efectiva para la recuperación funcional y permitido descubrir una ruta cortical alternativa a través del tracto descendente serotoninérgico, [CA] Lesió medul·lar traumàtica (LM) es una condició neurològica en la qual un traumatisme interromp la comunicació adequada dels impulsos a través del sistema nerviós central (SNC), amb el resultat de la pèrdua de la funció locomotora per baix de la zona lesionada. Lamentablement, en l'actualitat encara no hi ha una cura efectiva per a restaurar completament la funcionalitat de la medul·la espinal després de la lesió. La recerca d'un tractament eficient per a la LM roman un repte complex a causa de la nostra comprensió encara incompleta de la gran quantitat de processos biològics desencadenats per la lesió primària. La teràpia cel·lular destaca com l'aproximació més recurrent per al tractament de la LM. En les dècades passades, s'ha explorat diverses estratègies basades en cèl·lules i una de les més prometedores és el trasplantament de cèl·lules progenitores neurals (CPN). Molts estudis preclínics han demostrat el potencial del trasplantament de CPN per proporcionar una recuperació motora en models animals, no obstant això, les millores funcionals en pacients humans tractats són limitades. Per tant, encara s'han de fer esforços per a descobrir la cascada precisa de processos moleculars al llarg de la fisiopatologia de la LM, així com el mecanisme subjacent dels CPN. El Capítol 1 del present treball va tindre com a objectiu proporcionar una caracterització dels canvis en el perfil transcripcional espinal al la llarga de les diferents etapes temporals de una lesió contusiva. A més, s'ha descrit l'impacte transcripcional del trasplantament d'CPN en animals lesionats. S'ha demostrat que mentre la LM va causar una forta desregulació de diversos components de senyalització de AMPc (sent EPAC2 el gen més regulat a la baixa), el transplantament de CPN van ser capaç de restaurar les alteracions derivades de la LM. Per a explorar el paper d'EPAC2 en el mecanisme terapèutic mediat per CPN, es va realitzar un experiment de inhibició sostinguda d'EPAC2 degut a l'administració d'ESI en animals lesionats. En comparació amb els animals només trasplantats, els animals CPN+ESI-05 van mostrar un augment de l'àrea de cicatriu, una exacerbació de la polarització de les micròglies cap a un perfil inflamatori i una ampliació de la bretxa de neurones preservades a través de la lesió.Aquests resultats suggereixen que el trasplantament de CPN en el context de la LM involucren un mecanisme depenent d'EPAC2, reduint la neuroinflamació i proporcionant un entorn més neuropermissiu. El Capítol 2 va tindre com objectiu explotar el potencial de regeneració de AMPc dissenyant una nova estratègia per a les induccions artificials de AMPc en les neurones corticoespinals mitjançant l'activació optogenètica d'una adenilat ciclasa fotoinduïble (bPAC). L'estimulació diària de AMPc en rates que pateixen una hemisècció dorsal toràcica va promoure una recuperació en comparació amb els control. L'estimulació de bPAC va augmentar el nombre de neurones marcades retrògradament des del segment lumbar, tant a l'escorça motora com a la formació rafe-reticular, però no al nucli roig. A més, la immunotinció del tracte rafespinal va mostrar que l'estimulació de bPAC va augmentar la ràtio d'axons serotoninèrgic cabals a la lesió, cosa que es va correlacionar significativament amb una millora dels paràmetres funcionals. Finalment, la depleció del sistema serotoninèrgic mitjançant l'administració de 5,7-Dihydroxytryptamina va abolir la millora mediada per bPAC, confirmant la implicació de la via serotoninèrgica en la recuperació. En resum, la investigació ha proporcionat coneixements sobre els canvis transcripcionals que tenen lloc a la llarga de la progressió de la LM i després del trasplantament de CPN, amb un èmfasi especial en la senyalització d'AMPc. La manipulació optogenètica d'AMPc a les neurones corticoespinals després de la LM ha demostrat ser efectiva per a la recuperació funcional i ha permès descobrir una ruta cortical alternativa a través del tracte descendent serotoninèrg, [EN] Traumatic spinal cord injury (SCI) refers to a neurological condition in which a mechanic insult disrupts the proper communication of the impulses through the central nervous system (CNS), resulting on the loss of locomotor function below the injured area. Unfortunately, nowadays there is still no effective cure to completely restore the functionality of the spinal cord after the injury. Cell therapy is the most recurring approach for SCI treatment. In the past decades several cell-based strategies have been explored, being one of the most promising the transplantation of neural progenitor cells (NPCs). Many pre-clinical studies evidenced the potential of the NPCs transplantation to provide a substantial motor recovery in animal models, yet functional improvements in clinical trials have been limited. Therefore, efforts still need to be made in disclosing the precise cascade of molecular processes along SCI pathophysiology as well as the NPCs underlying mechanism. In that context, Chapter 1 of the present work aimed to provide a comprehensive characterization of the spinal transcriptional changes along the different temporal stages of rats suffering a severe contusive injury. Additionally, we have described the transcriptional impact of acute and subacute NPCs transplantation in injured animals. Interestingly we have shown that while SCI caused a strong dysregulation of several cAMP-signaling components (being EPAC2 the most downregulated gene), NPCs was able to restore SCI-derived alterations over this pathway with EPAC2 significant upregulation. In order to further explore EPAC2 role in NPCs-mediated therapeutical mechanism we performed a loss-of-function experiment by sustained EPAC2 inhibition via ESI-05 administration along with NPCs transplantation after SCI. Compared with only transplanted animals, NPCs+ESI-05 animals showed increased scar area, exacerbated microglia polarization into an inflammatory profile and widened gaps of preserved neurons across the lesion. Overall, these results suggest that NPC therapeutic mechanisms in the context of SCI involve an EPAC2-dependent mechanism, reducing neuroinflammation and providing a neuro-permissive environment. Chapter 2 aimed to further explore cAMP potential for SCI regeneration. We designed a novel strategy for artificial cAMP inductions in corticospinal neurons via optogenetic activation of a photoinducible adenylyl cyclase (bPAC). Daily optogenetic cAMP stimulation in rats suffering a thoracic dorsal hemisection, which completely disrupt the dorsal aspect of the corticospinal tract (CST), promoted and early and sustained locomotor recovery compared to non-treated control animals. We have shown that bPAC stimulation increased the number of retrograde traced neurons from the lumbar segment both in the motor cortex and the raphe-reticular formation, but not in the red nuclei. Moreover, immunolabelling of the raphespinal tract by 5-HT showed that bPAC stimulation increased the ratio of descending serotoninergic axons caudal to the injury which significantly correlated with improved functional parameters. Our results from corticobulbar projection study, WGA trans-synaptic tracing, and P-CREB analysis suggest that bPAC modulation of cortico-serotonergic pathway might occurs at the brainstem level. Lastly, the serotonergic system depletion by 5,7-Dihydroxytryptamine administration suppressed bPAC-mediated recovery, confirming the implication of the serotonergic tract in the recovery of stimulated animals. In summary, our research has provided new insights into the transcriptional changes that occur along SCI progression and after NPCs transplantation with a special emphasis on cAMP signaling. Optogenetic cAMP manipulation in corticospinal neurons after SCI has proven to be effective for functional recovery and allowed to unveil a cortical rerouting pathway through the serotonergic descending tract., This research was funded by FEDER/Ministerio de Ciencia e Innovación – Agencia Estatal de Investigación [RTI2018-095872-BC21/ERDF]. Part of the equipment employed in this work was funded by Generalitat Valenciana and cofinanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014– 2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) incluido en el Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. B. MartinezRojas was supported by a grant from the Conselleria de Educación, Investigación, Cultura y Deporte de la Generalitat Valenciana and the European Social Fundation ACIF/2019/120.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Strategies for Guidance and Electrical and Biological Stimulation in a Neural Regeneration Device

  • Gisbert-Roca, Fernando|||0000-0003-3937-5822
[ES] Actualmente las lesiones del sistema nervioso periférico que conllevan una pérdida de continuidad de los haces axonales suelen implicar secuelas de tipo permanente. Es cierto que en el sistema nervioso periférico existe una cierta regeneración natural de los tractos axonales dañados, pero solamente cuando el espacio entre ambos extremos de la lesión es pequeño, como máximo de 5 mm. Si el espacio es mayor que esta distancia la regeneración no sucede de forma natural y se crea un neuroma traumático. Por tanto, estas lesiones largas requieren de una intervención quirúrgica para puentear la lesión, normalmente con un nervio autógrafo del propio paciente o un nervio alógrafo de un cadáver. No obstante, su uso presenta diversos inconvenientes, como la morbilidad del sitio donante donde puede ocurrir un neuroma, la necesidad de realizar una segunda cirugía, la diferencia de tamaño entre nervio receptor y donante o la necesidad de inmunosupresión en el caso de los nervios alógrafos. Por ello, la ingeniería de tejidos trabaja en el desarrollo de los conductos de guiado nervioso que incorporan estrategias para guiar topográficamente la regeneración, así como células y moléculas bioactivas. La presente tesis doctoral presenta un nuevo conducto de guiado nervioso con una aproximación multimodular para su aplicación en la regeneración de lesiones nerviosas largas (a partir de 15 mm) que hace uso de conductos tubulares huecos modulares de ácido hialurónico (HA) que contienen en su interior una estructura tubular de microfibras de ácido poliláctico (PLA). La estructura fibrilar aporta un guiado topográfico necesario para guiar el crecimiento axonal durante la regeneración a la vez que mantiene unidos los diferentes módulos de HA. Por su parte, los conductos de HA son un hidrogel que evita adherencias con el tejido circundante. A su vez, proporcionan un soporte sobre el que pueden crecer células presembradas. En concreto se ha optado por presembrar células de Schwann, las cuales son unas células gliales de soporte críticas para la regeneración del sistema nervioso periférico. Se ha observado que dichas células son capaces recubrir por completo las paredes internas de los conductos de HA formando una estructura tipo vaina, así como de recubrir las microfibras de PLA creciendo en dirección longitudinal. Los experimentos in vivo en modelo de nervio ciático de conejo han mostrado que la aproximación multimodular mejora significativamente la regeneración nerviosa gracias a proporcionar una mejor neovascularización. A su vez, gracias a las células de Schwann presembradas se ha logrado una mejora adicional de la regeneración nerviosa gracias a su efecto favorecedor del crecimiento axonal. Además, se han estudiado diferentes mejoras aplicables al conducto de guiado nervioso con el objetivo de mejorar los resultados obtenidos in vivo. Gracias a la incorporación de fibroína de seda a los conductos de HA se ha logrado mejorar sus propiedades mecánicas y biológicas. Asimismo, también se ha desarrollado un sustrato electroconductor de microfibras de PLA recubiertas con el polímero electroconductor Polipirrol gracias al cual se ha observado in vitro que es capaz de mejorar el crecimiento axonal al aplicar una estimulación eléctrica. Además, mediante un sistema de modificación génica de las células de Schwann por electrotransfección se ha logrado aumentar su secreción del factor neurotrófico derivado del cerebro (BDNF), gracias a lo cual se ha observado que se incrementa la velocidad de crecimiento axonal in vitro., [CA] Actualment les lesions del sistema nerviós perifèric que comporten una pèrdua de continuïtat dels feixos axonals solen implicar seqüeles de tipus permanent. És cert que al sistema nerviós perifèric hi ha una certa regeneració natural dels tractes axonals danyats, però només quan l'espai entre ambdós extrems de la lesió és petit, com a màxim de 5 mm. Si l'espai és més gran que aquesta distància la regeneració no succeeix de manera natural i es crea un neuroma traumàtic. Per tant, aquestes lesions llargues requereixen una intervenció quirúrgica per pontejar la lesió, normalment amb un nervi autògraf del pacient o un nervi al·lògraf d'un cadàver. No obstant això, el seu ús presenta diversos inconvenients, com la morbilitat del lloc donant on pot ocórrer un neuroma, la necessitat de fer una segona cirurgia, la diferència de mida entre nervi receptor i donant o la necessitat d'immunosupressió en el cas dels nervis al·lògrafs . Per això, l'enginyeria de teixits treballa en el desenvolupament dels conductes de guiatge nerviós que incorporen estratègies per guiar topogràficament la regeneració, així com cèl·lules i molècules bioactives. Aquesta tesi doctoral presenta un nou conducte de guiatge nerviós amb una aproximació multimodular per a la seva aplicació en la regeneració de lesions nervioses llargues (a partir de 15 mm) que fa ús de conductes tubulars buits modulars d'àcid hialurònic (HA) que contenen al seu interior una estructura tubular de microfibres d'àcid polilàctic (PLA). L'estructura fibril·lar aporta un guiatge topogràfic necessari per guiar el creixement axonal durant la regeneració alhora que manté units els diferents mòduls d'HA. Per part seva, els conductes d'HA són un hidrogel que evita adherències amb el teixit circumdant. Alhora, proporcionen un suport sobre el qual poden créixer cèl·lules presembrades. En concret s'ha optat per presembrar cèl·lules de Schwann, les quals són unes cèl·lules glials de suport crítiques per a la regeneració del sistema nerviós perifèric. S'ha observat que aquestes cèl·lules són capaces de recobrir completament les parets internes dels conductes d'HA formant una estructura tipus beina, així com de recobrir les microfibres de PLA creixent en direcció longitudinal. Els experiments in vivo en model de nervi ciàtic de conill han mostrat que l'aproximació multimodular millora significativament la regeneració nerviosa gràcies a proporcionar una millor neovascularització. Alhora, gràcies a les cèl·lules de Schwann presembrades s'ha aconseguit una millora addicional de la regeneració nerviosa gràcies al seu efecte afavoridor del creixement axonal. A més, s'han estudiat diferents millores aplicables al conducte de guiatge nerviós per tal de millorar els resultats obtinguts in vivo. Gràcies a la incorporació de fibroïna de seda als conductes d'HA s'ha aconseguit millorar les seues propietats mecàniques i biològiques. També s'ha desenvolupat un substrat electroconductor de microfibres de PLA recobertes amb el polímer electroconductor Polipirrol gràcies al qual s'ha observat in vitro que és capaç de millorar el creixement axonal quan s'aplica una estimulació elèctrica. A més, mitjançant un sistema de modificació gènica de les cèl·lules de Schwann per electrotransfecció s'ha aconseguit augmentar la secreció del factor neurotròfic derivat del cervell (BDNF), gràcies a la qual cosa s'ha observat que s'incrementa la velocitat de creixement axonal in vitro., [EN] Currently, lesions of the peripheral nervous system that lead to a loss of continuity of the axonal bundles usually involve permanent sequelae. It is true that in the peripheral nervous system there is some natural regeneration of damaged axonal tracts, but only when the space between the two ends of the lesion is small, at most 5 mm. If the gap is greater than this distance, regeneration does not occur naturally, and a traumatic neuroma is created. Therefore, these long injuries require surgical intervention to bridge the injury, usually with an autograph nerve from the patient or an allograph nerve from a cadaver. However, its use has various drawbacks, such as the morbidity of the donor site where a neuroma can occur, the need to perform a second surgery, the difference in size between the recipient and donor nerves, or the need for immunosuppression in the case of allograft nerves. For this reason, tissue engineering works on the development of nerve guidance conduits that incorporate strategies to topographically guide the regeneration, as well as cells and bioactive molecules. This doctoral thesis presents a new nerve guidance conduit with a multimodular approach for its application in the regeneration of long nerve lesions (from 15 mm) that makes use of modular hollow tubular conduits of hyaluronic acid (HA) that contain in their inside a tubular structure of microfibers of polylactic acid (PLA). The fibrillar structure provides the necessary topographic guidance to guide axonal growth during regeneration while keeping the different HA modules together. For their part, the HA conduits are a hydrogel that prevents adhesions with the surrounding tissue. In turn, they provide a support on which preseeded cells can grow. Specifically, it has been decided to pre-seed Schwann cells, which are glial support cells that are critical for the regeneration of the peripheral nervous system. It has been observed that these cells are capable of completely covering the inner walls of the HA conduits, forming a sheath-like structure, as well as covering the PLA microfibers by growing in a longitudinal direction. In vivo experiments in a rabbit sciatic nerve model have shown that the multimodular approach significantly improves nerve regeneration by providing better neovascularization. In turn, thanks to the pre-seeded Schwann cells, an additional improvement in nerve regeneration has been achieved thanks to its promoting effect on axonal growth. In addition, different improvements applicable to the nerve guidance conduit have been studied with the aim of improving the results obtained in vivo. Thanks to the incorporation of silk fibroin into HA conduits, their mechanical and biological properties have been improved. Likewise, an electroconductive substrate of PLA microfibers coated with the electroconductive polymer Polypyrrole has also been developed, thanks to which it has been observed in vitro that it is capable of improving axonal growth by applying electrical stimulation. In addition, by means of a gene modification system of Schwann cells by electrotransfection, it has been possible to increase their secretion of brain-derived neurotrophic factor (BDNF), thanks to which it has been observed that the speed of axonal growth is increased in vitro., Agradezco la ayuda de los diferentes proyectos del Ministerio de Economía y Competitividad del Gobierno de España que han hecho posible la financiación de esta tesis doctoral: MAT2015-66666-C3-1-R, DPI2015-72863-EXP, AEI RTI2018-095872-B-C21-C22/ERDF y FPU16/01833 del Ministerio de Universidades del Gobierno de España, sin la cual no hubiera podido realizar esta tesis doctoral.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Toll-like receptors in spinal cord derived neural precursor cells: implications on spinal cord injury and cell transplantation

  • Sánchez Petidier, Marina
[ES] Los receptores tipo Toll, TLR, son receptores clave en la defensa contra los patógenos capaces de iniciar la respuesta inmunitaria innata para proteger al huésped. Su papel no solo se relega a responder a estímulos foráneos, sino que también pueden detectar daños en los tejidos o células lesionadas induciendo su respuesta a lo que se conoce como "inflamación estéril". Las células del sistema inmunitario no son las únicas que presentan TLR; también se encuentran en células de la glía, neuronas y precursores neurales (NPC). Concretamente, TLR2 y TLR4 en NPC en cerebro contribuyen a la determinación del destino celular y plasticidad neuronal durante el desarrollo. Sin embargo, sus funciones en la fisiología y patología de la médula espinal no están bien definidas, así como en procesos críticos como la neurogénesis, autorrenovación o proliferación. Esta tesis doctoral, distribuida entre tres capítulos, se ha centrado 1) en el estudio del papel de TLR2 y TLR4 en precursores derivados de medula espinal neonatal (Capítulo 1); 2) en evaluar el papel de ambos, TLR2 y TLR4 en el proceso de regeneración espontánea o tras trasplante ectópico de NPC, en un modelo de lesión medular inducida (Capítulo 2); 3) en el estudio del papel de TLR4 en la modulación del fenotipo inflamatorio en respuesta al proteoglicano condroitín sulfato (CSPG) secretado tras la lesión medular con actividad inhibitoria del recrecimiento axonal tras lesión medular (Capítulo 3)., [CA] Els receptors tipus Toll, TLR, són receptors clau en la defensa contra els patògens capaços d'iniciar la resposta immunitària innata per a protegir l'hoste. El seu paper no sols es relega a respondre a estímuls forans, sinó que també poden detectar danys en els teixits o cèl·lules lesionades induint la seua resposta al que es coneix com a "inflamació estèril". Les cèl·lules del sistema immunitari no són les úniques que presenten TLR; també es troben en cèl·lules de la glia, neurones i precursors neurals (NPC). TLR2 i TLR4 en NPC en cervell contribueixen a la determinació del destí cel·lular i plasticitat neuronal. No obstant això, les seues funcions en la fisiopatologia de la medul·la espinal no estan ben definides, així com en processos crítics com la neurogènesi, autorenovació o proliferació. Aquesta tesi doctoral, distribuïda entre tres capítols, s'ha centrat: 1) En l'estudi del paper de TLR2 i TLR4 en precursors derivats de medul·la espinal neonatal (Capítol 1); 2) A avaluar el paper de tots dos, TLR2 i TLR4, en el procés de regeneració espontània o després de trasplantament ectòpic de NPC, en un model de lesió medul·lar induïda (Capítol 2); 3) En l'estudi del paper de TLR4 en la modulació del fenotip inflamatori en resposta al proteoglicà condroití sulfat (CSPG) secretat després de la lesió medul·lar amb activitat inhibitòria del recreixement axonal després de lesió medul·lar (Capítol 3)., [EN] Toll-like receptors, TLRs, are key receptors in the defence against pathogens capable of initiating the innate immune response to protect the host. Their role is not only limited to responding to foreign stimuli, but they can also detect damage to injured tissues or cells, inducing their response to what is known as 'sterile inflammation'. Immune system cells are not the only cells that display TLRs; they are also found in glial cells, neurons and neural precursors cells (NPCs). TLR2 and TLR4 NPCs from brain contribute to cell fate determination and neuronal plasticity. However, their roles in spinal cord pathophysiology and in critical processes such as neurogenesis, self-renewal or proliferation are not well defined. This doctoral thesis, distributed among three chapters, has focused: 1) on the study of the role of TLR2 and TLR4 in neonatal spinal cord-derived precursors (Chapter 1); 2) on evaluating the role of both TLR2 and TLR4 in the process of spontaneous regeneration or after ectopic transplantation of NPC, in a model of induced spinal cord injury (Chapter 2); 3) to study the role of TLR4 in modulating the inflammatory phenotype in response to chondroitin sulphate proteoglycan (CSPG) secreted after spinal cord injury with inhibitory activity on axonal regrowth after spinal cord injury (Chapter 3)., The student has been granted with a PhD fellowship from a predoctoral program at the CIPF and with International Research and Training Exchange Programme at the CIPF. This work has been supported by the Spanish Ministry of Economy and Competitiveness (projects RTI2018-095872-B-C21; MAT2015-66666-C3-R; SAF2015-69187R) and Spanish Ministry of Heath, PNSD2018 I003.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Optogenetic Modulation of Neural Progenitor Cells Improves Neuroregenerative Potential

  • Giraldo, Esther|||0000-0001-5488-3011
  • Palmero-Canton, David
  • Martínez-Rojas, Beatriz
  • Sanchez-Martin, Maria del Mar
  • Moreno-Manzano, Victoria
[EN] Neural progenitor cell (NPC) transplantation possesses enormous potential for the treatment of disorders and injuries of the central nervous system, including the replacement of lost cells or the repair of host neural circuity after spinal cord injury (SCI). Importantly, cell-based therapies in this context still require improvements such as increased cell survival and host circuit integration, and we propose the implementation of optogenetics as a solution. Blue-light stimulation of NPCs engineered to ectopically express the excitatory light-sensitive protein channelrhodopsin-2 (ChR2-NPCs) prompted an influx of cations and a subsequent increase in proliferation and differentiation into oligodendrocytes and neurons and the polarization of astrocytes from a pro-inflammatory phenotype to a pro-regenerative/anti-inflammatory phenotype. Moreover, neurons derived from blue-light-stimulated ChR2-NPCs exhibited both increased branching and axon length and improved axon growth in the presence of axonal inhibitory drugs such as lysophosphatidic acid or chondroitin sulfate proteoglycan. Our results highlight the enormous potential of optogenetically stimulated NPCs as a means to increase neuroregeneration and improve cell therapy outcomes for enhancing better engraftments and cell identity upon transplantation in conditions such as SCI., This research was funded by FEDER/Ministerio de Ciencia e Innovacion-Agencia Estatal de Investigacion "RTI2018-095872-B-C21/ERDF", Fundacio La Marato de TV3 2017/refs. 20172230, 20172231 and 20172110, Agencia Valenciana de Innovacion (AVI) INNVAL10/19/047, ACIF2019 and MINECO/FEDER, UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014-2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Biohybrids for Neural Tracts Regeneration

  • Rodríguez Doblado, Laura
[ES] Las lesiones del sistema nervioso que implican la interrupción de haces axonales son devastadoras para el individuo. La regeneración autónoma de los tractos axonales dañados o degenerados es poco frecuente, ya que intervienen una gran cantidad de factores que limitan esta recuperación. Hoy en día, la medicina convencional no cuenta con tratamientos efectivos y exitosos para estas lesiones, y el tratamiento de los síntomas suele ser la mejor solución. Para revertirlo y lograr la reconexión funcional de las neuronas, la ingeniería de tejidos actualmente opta por el uso de soportes tridimensionales biocompatibles, células y moléculas bioactivas. Específicamente, una de las estrategias propuestas han sido los conductos nerviosos guiados, no solo para lesiones de nervios periféricos sino también para tractos del sistema nervioso central. En esta Tesis Doctoral, se propone la combinación de un conducto tubular hueco de ácido hialurónico (HA) relleno con fibras de ácido poli-L-lactida (PLA) en su lumen, y con células de Schwann (SC) pre-cultivadas como células de soporte de la extension axonal para superar los obstáculos que limitan la regeneración de axones in vivo. Se ha demostrado que el conducto de HA y las fibras de PLA mantienen la proliferación de las SC, las cuales forman una estructura cilíndica denominada 'vaina de SC' en la pared interna del lumen del conducto y a su vez crecen de forma direccional en las fibras de PLA. El conjunto unidireccional paralelo formado por las fibras PLA y las SC recapitula las características direccionales de los tractos axonales en el sistema nervioso. Al sembrar un explante de ganglio de la raíz dorsal (DRG) en uno de los extremos del conducto, se ha conseguido el crecimiento de los axones del DRG y se ha estudiado las características de las SC, los axones crecidos y su asociación, comprobando que el biohíbrido es capaz de soportar el crecimiento axonal. Además, se propone un concepto multimodular para superar las limitaciones típicas de la regeneración axonal a larga distancia, con la combinación de haces de fibras de PLA en el lumen de varios conductos o módulos de HA individuales más cortos que se posicionan uno detrás del otro, diseñando conductos nerviosos guiados con la longitud deseada, junto con SC pre-cultivadas. El conducto multimodular demostró ser eficaz para promover el crecimiento dirigido de axones. Además, se ha desarrollado un constructo compuesto por la estructura formada por las fibras de PLA y las SC, denominado 'cordón neural', tras eliminar el conducto de HA, lo que abre la puerta a la generación de una estructura neural in vitro para su trasplante., [CA] Les lesions de el sistema nerviós que impliquen la interrupció de feixos axonals són devastadores per a l'individu. La regeneració autònoma dels tractes axonals danyats o degenerats és poc freqüent, ja que intervenen una gran quantitat de factors que limiten aquesta recuperació. Avui dia, la medicina convencional no compta amb tractaments efectius i reeixits per aquestes lesions, i el tractament dels símptomes sol ser la millor solució. Per revertir i aconseguir la reconnexió funcional de les neurones, l'enginyeria de teixits actualment opta per l'ús de suports tridimensionals biocompatibles, cèl·lules i molècules bioactives. Específicament, una de les estratègies proposades han estat els conductes nerviosos guiats, no només per lesions de nervis perifèrics sinó també per tractes de sistema nerviós central. En aquesta tesi doctoral, es proposa la combinació d'un conducte tubular buit d'àcid hialurònic (HA) farcit amb fibres d'àcid poli-L-lactida (PLA) en el seu lumen, i amb cèl·lules de Schwann (SC) pre-cultivades com a cèl·lules de suport de l'extension axonal per superar els obstacles que limiten la regeneració d'axons in vivo. S'ha demostrat que el conducte d'HA i les fibres de PLA mantenen la proliferació de les SC, les quals formen una estructura cilíndica anomenada 'beina de SC' a la paret interna de l'lumen de l'conducte i al seu torn creixen de manera direccional en les fibres de PLA. El conjunt unidireccional paral·lel format per les fibres PLA i les SC recapitula les característiques direccionals dels tractes axonals en el sistema nerviós. A l'sembrar un explantament de gangli de l'arrel dorsal (DRG) en un dels extrems de l'conducte, s'ha seguit el creixement dels axons de l'DRG i s'ha estudiat les característiques de les SC, els axons crescuts i la seva associació, comprovant que el biohíbrido és capaç de suportar el creixement axonal. A més, es proposa un concepte multimodular per superar les limitacions típiques de la regeneració axonal a llarga distància, amb la combinació de feixos de fibres de PLA en el lumen de diversos conductes o mòduls de HA individuals més curts que es posicionen un darrere l'l'altre, dissenyant conductes nerviosos guiats amb la longitud desitjada, juntament amb SC pre-cultivades. El conducte multimodular va demostrar ser eficaç per promoure el creixement dirigit d'axons. A més, s'ha desenvolupat un constructe format per l'estructura formada per les fibres de PLA i les SC, denominat 'cordó neural', després d'eliminar el conducte d'HA, el que obre la porta a la generació d'una estructura neural in vitro per al seu trasplantament., [EN] Injuries to the nervous system that involve the disruption of axonal bundles are devastating to the individual. Autonomous regeneration of damaged or degenerated axonal tracts is infrequent since a large number of factors are involved limiting this recovery. Nowadays, conventional medicine does not have effective and successful treatments for these injuries, and the treatment of symptoms is often the best solution. In order to reverse it and achieve the functional reconnection of neurons, tissue engineering currently opts for the use of biocompatible three-dimensional supports, cells, and bioactive molecules. Specifically, one of the proposed strategies has been nerve guidance conduits, not only for peripheral nerve injuries but also for tracts of the central nervous system. In this Doctoral Thesis, we propose the combination of hyaluronic acid (HA) single-channel tubular conduit filled with poly-L-lactide acid (PLA) fibres in its lumen, with pre-cultured Schwann cells (SC) as cells supportive of axon extension to overcome the obstacles limiting axon regeneration in vivo. We have proved that HA conduit and PLA fibres sustain the proliferation of SC, which form a cylindrical structure named 'SC sheath' on the inner wall of the lumen of the conduit and in turn grow directionally in the PLA fibres. The parallel unidirectional ensemble formed by PLA fibres and SC recapitulates the directional features of axonal pathways in the nervous system. Planting a dorsal root ganglion (DRG) explant on one of the conduit's ends, we have followed axon outgrowth from the DRG and studied the features of SC, the grown axons and their association, checking that the biohybrid is capable of supporting axonal growth. Furthermore, we propose a multimodular concept to overcome the typical limitations of long-distance axonal regeneration, with the combination of PLA fibres bundle in the lumen of several shorter individual HA conduits or modules which positioned themselves one behind the other, designing nerve guided conduits with the desired length, together with pre-cultured SC. The multimodular conduit proved effective in promoting directed axon growth. Moreover, we developed a construct consisting of the structure formed by the PLA fibres and the SC, named 'neural cord', after eliminating the HA conduit, that opens the door to the generation of a neural structure in vitro for transplantation., La presente tesis doctoral se ha realizado con la financiación del Ministerio de Economía y Competitividad a través de los proyectos MAT2015-66666-C3-1-R, DPI2015-72863-EXP, y AEI RTI2018-095872-B-C21-C22/ERDF. Agradezco también la beca FPU15/04975 al Ministerio de Educación Cultura y Deportes.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Study of Combinatorial Cell Therapy and Neuroprotective Agents for the Treatment of Spinal Cord Injury in Experimental Models

  • Bonilla Villamil, Pablo
[ES] La lesión medular (LM) es un trastorno neurológico devastador y debilitante que se caracteriza por un grado variable de disfunción motora, sensorial y/o autonómica permanente. El trasplante de células madre neurales (NSC) ofrece una herramienta terapéutica prometedora para el tratamiento de la LM al proporcionar neuroprotección y neuroregeneración. Sin embargo, el entorno generado tras la lesión limita el potencial terapéutico de las terapias celulares al dar lugar a una escasa supervivencia y engraftment de las células y a una diferenciación inadecuada. Además, las terapias celulares han mostrado hasta la fecha una recuperación funcional limitada en los ensayos clínicos. Por lo tanto, se ha postulado el uso de terapias combinatorias para superar estas limitaciones y potenciar los beneficios terapéuticos de las terapias celulares. En esta tesis doctoral, se han estudiado distintas estrategias de combinación con el trasplante de NSC, como el uso de fármacos y biomateriales, con el objetivo de mejorar y potenciar el efecto de la terapia celular en el rescate de la actividad neuronal, en la modulación del proceso inflamatorio, en la supervivencia del trasplante, así como en su integración y diferenciación en el tejido medular. Así, En el capítulo 1 evaluamos la terapia combinada de células madre neurales humanas derivadas de células madre pluripotentes inducidas (iPSC-NSCs), células madre mesenquimales (MSCs) y un nanoconjugado de curcumina (PA-C) en un modelo de LM subagudo, proporcionando un mayor grado de neuroprotección en comparación con los tratamientos individuales. En el capítulo 2 desarrollamos una estrategia mínimamente invasiva mediante el uso de un scaffold de ácido hialurónico en forma de semi-luna para el transplante de iPSC-NSCs combinado con PA-C. Así, los análisis histológicos demostraron que el tratamiento combinado de iPSC-NSCs y la PA-C presentaban una mayor preservación de fibras neuronales en la zona de la lesión y una reducción de la extensión de la cicatriz fibrótica. Por último, en el capítulo 3 se describe una estrategia terapéutica que se aproxima más a la traslación clínica mediante el trasplante de progenitores neurales fetales humanos (hfNPCs) condicionados previamente con una forma conjugada del inhibidor de Rho/Rock fasudil (PGA-SS-FAS). Así, la combinación de las hfNPCs con el PGA-SS-FAS favoreció la migración del transplante en el tejido medular, la preservación de las interneuronas somatosensoriales Lbx1 inhibitorias y las Tlx3 excitatorias, así como la activación neuronal alrededor del epicentro de la lesión. Así pues, en la presente tesis doctoral se estudia y describe el beneficio aportado por tres estrategias combinatorias, que incrementan los efectos neuroprotectores proporcionados por la terapia celular en el tratamiento de lesiones medulares agudas y sub-agudas., [CA] La lesió medul·lar (LM) és un trastorn neurològic devastador i debilitant que es caracteritza per un grau variable de disfunció motora, sensorial i/o autonòmica permanent. El trasplantament de cèl·lules mare neurals (NSC) ofereix una eina terapèutica prometedora per al tractament de la LM proporcionant neuroprotecció i neuroregeneració. Tot i això, l'entorn generat després de la lesió limita el potencial terapèutic de les teràpies cel·lulars donant lloc a una escassa supervivència i engraftment de les cèl·lules i a una diferenciació inadequada. A més, les teràpies cel·lulars han mostrat fins ara una recuperació funcional limitada als assajos clínics. Per tant, s'ha postulat l'ús de teràpies combinatòries per superar aquestes limitacions i potenciar els beneficis terapèutics de les teràpies cel·lulars. En aquesta tesi doctoral, s'han estudiat diferents estratègies de combinació amb el trasplantament de NSC, com ara l'ús de fàrmacs i biomaterials, amb l'objectiu de millorar i potenciar l'efecte de la teràpia cel·lular en el rescat de l'activitat neuronal, en la modulació del procés inflamatori, en la supervivència del trasplantament, així com en la seva integració i diferenciació al teixit medul·lar. Així, Al capítol 1 avaluem la teràpia combinada de cèl·llules mare neurals humanes derivades de cèl·lules mare pluripotents induïdes (iPSC-NSCs), cèl·lules mare mesenquimals (MSCs) i un nanoconjugat de curcumina (PA-C) en un model de LM subagut, proporcionant un major grau de neuroprotecció en comparació dels tractaments individuals. Al capítol 2 desenvolupem una estratègia mínimament invasiva mitjançant l'ús d'un scaffold d'àcid hialurònic en forma de semilluna per al trasplantament d'iPSC-NSC combinat amb PA-C. Així, els anàlisis histològics mostraren que el tractament combinat d'iPSC-NSCs i la PA-C incrementaba la preservació de fibres neuronals a la zona de la lesió i reduïa l'extensió de la cicatriu fibròtica. Finalment, al capítol 3 es descriu una estratègia terapèutica que s'aproxima més a la translació clínica mitjançant el trasplantament de progenitors neurals fetals humans (hfNPCs) condicionats prèviament amb una forma conjugada de l'inhibidor de Rho/Rock fasudil (PGA-SS-FAS. Així, la combinació de les hfNPCs amb el PGA-SS-FAS va afavorir la migració del trasplantament al teixit medul·lar, la preservació de les interneurones somatosensorials Lbx1 inhibitòries i les Tlx3 excitatòries, així com l'activació neuronal al voltant de l'epicentre de la lesió. Així doncs, en aquesta tesi doctoral s'estudia i descriu el benefici aportat per tres estratègies combinatòries, que incrementen els efectes neuroprotectors proporcionats per la teràpia cel·lular en el tractament de lesions medul·lars agudes i sub-agudes., [EN] Spinal cord injury (SCI) is a devastating and debilitating neurological disorder characterized by a variable degree of permanent motor, sensory and/or autonomic dysfunction. Neural stem cell (NSC) transplantation offers a promising therapeutic tool for the treatment of SCI by providing neuroprotection and neuroregeneration. However, the environment generated after injury limits the therapeutic potential of cell therapies by resulting in poor cell survival and engraftment and inadequate differentiation. In addition, cell therapies have shown limited functional recovery in clinical trials to date. Therefore, the use of combinatorial therapies has been postulated to overcome these limitations and enhance the therapeutic benefits of cell therapies. In this doctoral thesis, we have studied different combination strategies with NSC transplantation, such as the use of drugs and biomaterials, with the aim of improving and enhancing the effect of cell therapy in the rescue of neuronal activity, in the modulation of the inflammatory process, in the survival of the transplant, as well as in its integration and differentiation in the medullary tissue. Thus, In Chapter 1 we evaluated the combined therapy of human induced pluripotent stem cell-derived neural stem cells (iPSC-NSCs), mesenchymal stem cells (MSCs) and a curcumin nanoconjugate (PA-C) in a subacute LM model, providing a higher degree of neuroprotection compared to single treatments. In Chapter 2, we developed a minimally invasive strategy by using a demilune hyaluronic acid scaffold for combined transplantation of iPSC-NSCs with PA-C. Thus, histological analyses demonstrated that the combined treatment of iPSC-NSCs and PA-C exhibited increased preservation of neuronal fibers in the lesion area and a reduction in the extension of the fibrotic scar. Finally, Chapter 3 describes a therapeutic strategy that more closely approximates clinical translation by transplanting human fetal neural progenitors (hfNPCs) preconditioned with a conjugated form of the Rho/Rock inhibitor fasudil (PGA-SS-FAS). Thus, the combination of hfNPCs with PGA-SS-FAS favored transplant migration within the spinal parenchyma, preservation of endogenous inhibitory Lbx1 and excitatory Tlx3 somatosensory interneurons, as well as endogenous neuronal activation around the lesion epicenter. Thus, this PhD thesis studies and describes the benefit provided by three combinatorial strategies, which increase the neuroprotective effects provided by cell therapy in the treatment of acute and sub-acute spinal cord injury., This research was funded by Fundació Marató TV3 2017/refs.20172230, 20172231 and 20172110; FEDER/Ministerio de Ciencia e Innovación–Agencia Estatal de Investigación “RTI2018- 095872-B-C21/ERDF”, Agencia Valenciana de Innovación (AVI) INNVAL10/19/047 and TERCEL (RD12/0019/0011) funds from the Instituto de Salud Carlos III of Spain; Science by Women program, Women for Africa Foundation to HE and the grants FEDER/Ministerio de Ciencia e Innovación – Agencia Estatal de Investigación [RTI2018-095872-B-C21 and –C22/ERDF]; RISEUP project FetOpen in H2020 Program: H2020-ETOPEN-2018-2019-2020-01 and by Grants RTI2018-095872-B-C21 and PDI2021-1243590B-I00/ERDF funded by MCIN/AEI//10.13039/501100011033 and by ERDF A way of making Europe). This project was also funded by Project 964562 (RISEUP), H2020 FetOpen program
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Fetal rat neural progenitor cell transplantation after spinal cord injury improves motor recovery following optogenetic stimulation

  • Sanchez-Martin, Maria del Mar
  • Alastrue-Agudo, Ana
  • López-Mocholí, Eric
  • Martín-Pérez, Samuel
  • Maninno, Lois
  • Fraga Sánchez, Ana Isabel
  • Vidal-Beneyto, Quique
  • Conesa, Ana
  • van Niekerk, Erna
  • Tuszynski, Mark
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Paniagua G
  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
[EN] Spinal cord injury (SCI) disrupts communication between the brain and the spinal circuits, resulting in severe motor, sensory, and autonomic dysfunctions. Transplantation of neural progenitor cells (NPCs) has been demonstrated to provide multiple benefits; however, limited graft survival and neuronal differentiation must be overcome to achieve improved results. Here, we explore the optogenetic modulation of rat spinal cord-derived NPC expressing channelrhodopsin-2 (ChR2) through adeno-associated virus serotype 9-mediated transduction, transplanted into the sub-acute stage after SCI. Daily blue-light stimulation and ChR2-dependent activation control of the modified NPC significantly enhanced locomotor skills, run speed, sustained walking coordination, and body stability in a rat SCI model. Engrafted rat NPC-ChR2 reduces astrocytic reactivity and the injured area volume, preserves a higher number of descending propriospinal neurons above the injury and a higher innervation of 5-hydroxytryptamine fibers to choline acetyltransferase-positive motoneurons below the injury, and the increased vesicular glutamate transporter expression suggests an enhanced excitatory synaptic activity. Overall, sustained activation of rat NPC post-transplantation offers a promising strategy for improved locomotor recovery following SCI., The publication of the present research is funded and part of the projects PID2021-1243590B-I100 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU and RTI2018-095872-B-C21 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU, "Una manera de hacer Europa," and by the Generalitat Valenciana (GVA) PROMETEO grant CIPROM/2022/25 (to V.M.M) . The GVA also funded part of the equipment employed in this work and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. The authors also thank Dr. Beatriz Martinez Rojas, Dr. Sonia Jai Hingorani, and Dr. Maria Pedraza for their scientific discussion and suggestions; Marta Llansona for her technical support in chromatographic measurements; and Stuart P. Atkinson for English editing.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chondroitin sulfate proteoglycans prevent immune cell phenotypic conversion and inflammation resolution via TLR4 in rodent models of spinal cord injury

  • Francos-Quijorna, Isaac
  • Sánchez-Petidier, Marina
  • Burnside, Emily R.
  • Badea, Smaranda R.
  • Torres-Espin, Abel
  • Marshall, Lucy
  • de Winter, Fred
  • Verhaagen, Joost
  • Moreno-Manzano, Victoria
  • Bradbury, Elizabeth J.
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplasticity after spinal cord injury (SCI). Here we reveal that CSPGs also play a critical role in preventing inflammation resolution by blocking the conversion of pro-inflammatory immune cells to a pro-repair phenotype in rodent models of SCI. We demonstrate that enzymatic digestion of CSPG glycosaminoglycans enhances immune cell clearance and reduces pro-inflammatory protein and gene expression profiles at key resolution time points. Analysis of phenotypically distinct immune cell clusters revealed CSPG-mediated modulation of macrophage and microglial subtypes which, together with T lymphocyte infiltration and composition changes, suggests a role for CSPGs in modulating both innate and adaptive immune responses after SCI. Mechanistically, CSPG activation of a pro-inflammatory phenotype in pro-repair immune cells was found to be TLR4-dependent, identifying TLR4 signalling as a key driver of CSPG-mediated immune modulation. These findings establish CSPGs as critical mediators of inflammation resolution failure after SCI in rodents, which leads to prolonged inflammatory pathology and irreversible tissue destruction., The work was supported by grants from the following organisations: the U.K. Medical Research Council (SNCF G1002055; ERA-NET NEURON MR/R005532/1) and the Rosetrees Trust (CF1\100006) to E.J.B.; the Fondo Europeo de Desarrollo Regional (FEDER)/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación “RTI2018-095872-B-C21/ERDF” (included in the FEDER programme for the Comunidad Valenciana 2014-2020) to V.M.M.; and Wings for Life Spinal Cord Research Foundation (WFL-UK-01/20 Project 214 to E.J.B.; WFL-NL-25/20 Project 238 to J.V.). We thank Dr. S. Akira (Osaka) and Dr C. Guerri for providing TLR4−/− mice.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chondroitin sulfate proteoglycans prevent immune cell phenotypic conversion and inflammation resolution via TLR4 in rodent models of spinal cord injury

  • Francos-Quijorna, Isaac
  • Sánchez-Petidier, Marina
  • Burnside, Emily R.
  • Badea, Smaranda R.
  • Torres-Espin, Abel
  • Marshall, Lucy
  • de Winter, Fred
  • Verhaagen, Joost
  • Moreno-Manzano, Victoria
  • Bradbury, Elizabeth J.
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplasticity after spinal cord injury (SCI). Here we reveal that CSPGs also play a critical role in preventing inflammation resolution by blocking the conversion of pro-inflammatory immune cells to a pro-repair phenotype in rodent models of SCI. We demonstrate that enzymatic digestion of CSPG glycosaminoglycans enhances immune cell clearance and reduces pro-inflammatory protein and gene expression profiles at key resolution time points. Analysis of phenotypically distinct immune cell clusters revealed CSPG-mediated modulation of macrophage and microglial subtypes which, together with T lymphocyte infiltration and composition changes, suggests a role for CSPGs in modulating both innate and adaptive immune responses after SCI. Mechanistically, CSPG activation of a pro-inflammatory phenotype in pro-repair immune cells was found to be TLR4-dependent, identifying TLR4 signalling as a key driver of CSPG-mediated immune modulation. These findings establish CSPGs as critical mediators of inflammation resolution failure after SCI in rodents, which leads to prolonged inflammatory pathology and irreversible tissue destruction., The work was supported by grants from the following organisations: the U.K. Medical Research Council (SNCF G1002055; ERA-NET NEURON MR/R005532/1) and the Rosetrees Trust (CF1\100006) to E.J.B.; the Fondo Europeo de Desarrollo Regional (FEDER)/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación “RTI2018-095872-B-C21/ERDF” (included in the FEDER programme for the Comunidad Valenciana 2014-2020) to V.M.M.; and Wings for Life Spinal Cord Research Foundation (WFL-UK-01/20 Project 214 to E.J.B.; WFL-NL-25/20 Project 238 to J.V.). We thank Dr. S. Akira (Osaka) and Dr C. Guerri for providing TLR4−/− mice.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fetal rat neural progenitor cell transplantation after spinal cord injury improves motor recovery following optogenetic stimulation

  • Sánchez-Martín, María del Mar
  • Giraldo, Esther
  • Vidal Beneyto, Quique
  • Conesa, Ana
  • Moreno-Manzano, Victoria
The authors declare no competing interests: et al., Spinal cord injury (SCI) disrupts communication between the brain and the spinal circuits, resulting in severe motor, sensory, and autonomic dysfunctions. Transplantation of neural progenitor cells (NPCs) has been demonstrated to provide multiple benefits; however, limited graft survival and neuronal differentiation must be overcome to achieve improved results. Here, we explore the optogenetic modulation of rat spinal cord-derived NPC expressing channelrhodopsin-2 (ChR2) through adeno-associated virus serotype 9-mediated transduction, transplanted into the sub-acute stage after SCI. Daily blue-light stimulation and ChR2-dependent activation control of the modified NPC significantly enhanced locomotor skills, run speed, sustained walking coordination, and body stability in a rat SCI model. Engrafted rat NPC-ChR2 reduces astrocytic reactivity and the injured area volume, preserves a higher number of descending propriospinal neurons above the injury and a higher innervation of 5-hydroxytryptamine fibers to choline acetyltransferase-positive motoneurons below the injury, and the increased vesicular glutamate transporter expression suggests an enhanced excitatory synaptic activity. Overall, sustained activation of rat NPC post-transplantation offers a promising strategy for improved locomotor recovery following SCI., The publication of the present research is funded and part of the projects PID2021-1243590B-I100 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU and RTI2018-095872-B-C21 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU, “Una manera de hacer Europa,” and by the Generalitat Valenciana (GVA) PROMETEO grant CIPROM/2022/25 (to V.M.M). The GVA also funded part of the equipment employed in this work and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014–2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014–2020., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human-induced neural and mesenchymal stem cell therapy combined with a curcumin nanoconjugate as a spinal cord injury treatment

  • Bonilla, Pablo
  • Hernández Martín, Joaquim|||0000-0003-1409-5568
  • Giraldo, Esther
  • González-Pérez, Miguel A.
  • Alastrue-Agudo, Ana|||0000-0002-9326-2119
  • Elkhenany, Hoda|||0000-0003-2638-8640
  • Vicent, María J.
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Edel, Michael J.|||0000-0002-5619-8680
  • Moreno-Manzano, Victoria|||0000-0002-6035-9491
We currently lack effective treatments for the devastating loss of neural function associated with spinal cord injury (SCI). In this study, we evaluated a combination therapy comprising human neural stem cells derived from induced pluripotent stem cells (iPSC-NSC), human mesen-chymal stem cells (MSC), and a pH-responsive polyacetal-curcumin nanoconjugate (PA-C) that al-lows the sustained release of curcumin. In vitro analysis demonstrated that PA-C treatment pro-tected iPSC-NSC from oxidative damage in vitro, while MSC co-culture prevented lipopolysaccha-ride-induced activation of nuclear factor-κB (NF-κB) in iPSC-NSC. Then, we evaluated the combination of PA-C delivery into the intrathecal space in a rat model of contusive SCI with stem cell transplantation. While we failed to observe significant improvements in locomotor function (BBB scale) in treated animals, histological analysis revealed that PA-C-treated or PA-C and iPSC-NSC + MSC-treated animals displayed significantly smaller scars, while PA-C and iPSC-NSC + MSC treatment induced the preservation of β-III Tubulin-positive axons. iPSC-NSC + MSC transplantation fostered the preservation of motoneurons and myelinated tracts, while PA-C treatment polarized microglia into an anti-inflammatory phenotype. Overall, the combination of stem cell transplantation and PA-C treatment confers higher neuroprotective effects compared to individual treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A hyaluronic acid demilune scaffold and polypyrrole-coated fibers carrying embedded human neural precursor cells and curcumin for surface capping of spinal cord injuries

  • Elkhenany, Hoda|||0000-0003-2638-8640
  • Bonilla, Pablo
  • Giraldo, Esther
  • Alastrue-Agudo, Ana|||0000-0002-9326-2119
  • Edel, Michael J.|||0000-0002-5619-8680
  • Vicent, María Jesús
  • Gisbert Roca, Fernando
  • Marínez Ramos, Cristina
  • Rodríguez Doblado, Laura
  • Monleón Pradas, Manuel
  • Moreno Manzano, Victoria
Tissue engineering, including cell transplantation and the application of biomaterials and bioactive molecules, represents a promising approach for regeneration following spinal cord injury (SCI). We designed a combinatorial tissue-engineered approach for the minimally invasive treatment of SCI-a hyaluronic acid (HA)-based scaffold containing polypyrrole-coated fibers (PPY) combined with the RAD16-I self-assembling peptide hydrogel (Corning® PuraMatrix™ peptide hydrogel (PM)), human induced neural progenitor cells (iNPCs), and a nanoconjugated form of curcumin (CURC). In vitro cultures demonstrated that PM preserves iNPC viability and the addition of CURC reduces apoptosis and enhances the outgrowth of Nestin-positive neurites from iNPCs, compared to non-embedded iNPCs. The treatment of spinal cord organotypic cultures also demonstrated that CURC enhances cell migration and prompts a neuron-like morphology of embedded iNPCs implanted over the tissue slices. Following sub-acute SCI by traumatic contusion in rats, the implantation of PM-embedded iNPCs and CURC with PPY fibers supported a significant increase in neuro-preservation (as measured by greater βIII-tubulin staining of neuronal fibers) and decrease in the injured area (as measured by the lack of GFAP staining). This combination therapy also restricted platelet-derived growth factor expression, indicating a reduction in fibrotic pericyte invasion. Overall, these findings support PM-embedded iNPCs with CURC placed within an HA demilune scaffold containing PPY fibers as a minimally invasive combination-based alternative to cell transplantation alone.